Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Quality of Life Research
Published in: Quality of Life Research 2/2014

Open Access 01-03-2014

Swedish experience-based value sets for EQ-5D health states

Authors: Kristina Burström, Sun Sun, Ulf-G Gerdtham, Martin Henriksson, Magnus Johannesson, Lars-Åke Levin, Niklas Zethraeus

Published in: Quality of Life Research | Issue 2/2014

Login to get access

Abstract

Purpose

To estimate Swedish experience-based value sets for EQ-5D health states using general population health survey data.

Methods

Approximately 45,000 individuals valued their current health status by means of time trade off (TTO) and visual analogue scale (VAS) methods and answered the EQ-5D questionnaire, making it possible to model the association between the experience-based TTO and VAS values and the EQ-5D dimensions and severity levels. The association between TTO and VAS values and the different severity levels of respondents’ answers on a self-rated health (SRH) question was assessed.

Results

Almost all dimensions (except usual activity) and severity levels had less impact on TTO valuations compared with the UK study based on hypothetical values. Anxiety/depression had the greatest impact on both TTO and VAS values. TTO and VAS values were consistently related to SRH. The inclusion of age, sex, education and socioeconomic group affected the main effect coefficients and the explanatory power modestly.

Conclusions

A value set for EQ-5D health states based on Swedish valuations has been lacking. Several authors have recently advocated the normative standpoint of using experience-based values. Guidelines of economic evaluation for reimbursement decisions in Sweden recommend the use of experience-based values for QALY calculations. Our results that anxiety/depression had the greatest impact on both TTO and VAS values underline the importance of mental health for individuals’ overall HRQoL. Using population surveys is in line with recent thinking on valuing health states and could reduce some of the focusing effects potentially appearing in hypothetical valuation studies.
Appendix
Available only for authorised users
Literature
1.
Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol group. Annals of Medicine, 33(5), 337–343.PubMedCrossRef
2.
Burström, K., Johannesson, M., & Diderichsen, F. (2003). The value of the change in health in Sweden 1980/81 to 1996/97. Health Economics, 12(8), 637–654.PubMedCrossRef
3.
Devlin, N. J., Parkin, D., & Browne, J. (2010). Patient-reported outcome measures in the NHS: new methods for analysing and reporting EQ-5D data. Health Economics, 19(8), 886–905.PubMedCrossRef
4.
Drummond, M. F., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005). Methods for the economic evaluation of health care programmes (3rd ed.). New York: Oxford Medical Publications.
5.
6.
7.
Dolan, P. (2000). The measurement for health-related quality-of-life for use in resource allocation decisions in health care. In A. J. Culyer & J. Newhouse (Eds.), Handbook of health economics (pp. 1723–1760). Amsterdam: North-Holland.
8.
Mann, R., Brazier, J., & Tsuchiya, A. (2009). A comparison of patient and general population weightings of EQ-5D dimensions. Health Economics, 18(3), 363–372.PubMedCrossRef
9.
Szende, A., Oppe, M., & Devlin, N. (Eds.). (2007). EQ-5D value sets: Inventory, comparative review and user guide. Dordrecht: Springer.
10.
Ubel, P. A., Loewenstein, G., Hershey, J., Baron, J., Mohr, T., Asch, D., et al. (2001). Do nonpatients underestimate the quality of life associated with chronic health conditions because of a focusing illusion? Medical Decision Making, 21(3), 190–199.PubMedCrossRef
11.
Stolk, E. A., Oppe, M., Scalone, L., & Krabbe, P. F. M. (2010). Discrete choice modeling for the quantification of health states: The case of the EQ-5D. Value in Health, 13(8), 1005–1013.PubMedCrossRef
12.
Brazier, J., Akehurst, R., Brennan, A., Dolan, P., Claxton, K., McCabe, C., et al. (2005). Should patients have a great role in valuing health states? Applied Health Economics and Health Policy, 4(4), 201–208.PubMedCrossRef
13.
Burström, K., Johannesson, M., & Diderichsen, F. (2006). A comparison of individual and social time trade-off values for health states in the general population. Health Policy, 76(3), 359–370.PubMedCrossRef
14.
Dolan, P. (2008). Developing methods that really do value the ‘Q’ in the QALY. Health Economics, Policy and Law, 3, 69–77.
15.
Dolan, P., & Kahneman, D. (2008). Interpretations of utility and their implications for the valuation of health. The Economic Journal, 118, 215–234.CrossRef
16.
Dolan, P. (2011). Thinking about it: Thoughts about health and valuing QALYs. Health Economics, 20(12), 1407–1416.PubMedCrossRef
17.
Insinga, R. P., & Fryback, D. G. (2003). Understanding differences between self-ratings and populations ratings for health in the EuroQOL. (2003). Quality of Life Research, 12(6), 611–619.PubMedCrossRef
18.
Johannesson, M., Jonsson, B., & Karlsson, G. (1996). Outcome measurement in economic evaluation. Health Economics, 5(4), 279–296.PubMedCrossRef
19.
Krabbe, P. F. M., Tromp, N., Ruers, T. J. M., & van Riel, P. L. C. M. (2011). Are patients’ judgements of health status really different from the general population? Health and Quality of Life Outcomes, 9, 31.PubMedCentralPubMedCrossRef
20.
McNamee, P. (2007). What difference does it make? The calculation of QALY gains from health profiles using patient and general population values. Health Policy, 84(2–3), 321–331.PubMedCrossRef
21.
McPherson, K., Myers, J., Talor, W. J., McNaughton, H. K., & Weatherall, M. (2004). Self-valuation and societal valuations of health state differ with disease severity in chronic and disabling conditions. Medical Care, 42(11), 1143–1151.PubMedCrossRef
22.
de Wit, G. A., Busschbach, J. J., & de Charro, F. T. (2000). Sensitivity and perspective in valuation of health status: Whose values count? Health Economics, 9(2), 109–126.PubMedCrossRef
23.
Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35(11), 1095–1108.PubMedCrossRef
24.
Greiner, W., Weijnen, T., Nieuwenhuizen, M., Oppe, S., Busschbach, J., Buxton, M., et al. (2003). A single European currency for EQ-5D health states. European Journal of Health Economics, 4(3), 222–231.PubMedCrossRef
25.
Zarate, V., Kind, P., & Chuang, L. H. (2008). Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans. Value in Health, 11(7), 1170–1177.PubMedCrossRef
26.
Badia, X., Roset, M., Herdman, M., & Kind, P. (2001). A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Medical Decision Making, 21(1), 7–16.PubMedCrossRef
27.
Bailey, H., & Kind, P. (2010). Preliminary findings of an investigation into the relationship between national culture and EQ-5D value sets. Quality of Life Research, 19(8), 1145–1154.PubMedCrossRef
28.
Busschbach, J. J., Weijnen, T., Nieuwenhuizen, M., Oppe, S., Badia, X., Dolan, P., et al. (2003). A comparison of EQ-5D time trade-off values obtained in Germany, the United Kingdom and Spain. In R. Brooks, R. Rabin, & F. de Charro (Eds.), The measurement and valuation of health status using EQ-5D: A European perspective (pp. 143–165). Dordrecht: Kluwer Academic.CrossRef
29.
Johnson, J. A., Luo, N., Shaw, J. W., Kind, P., & Coons, S. J. (2005). Valuations of EQ-5D health states. Are the United States and United Kingdom different? Medical Care, 43(3), 221–228.PubMedCrossRef
30.
Kharroubi, S. A., O’Hagan, A., & Brazier, J. E. (2010). A comparison of United States and United Kingdom EQ-5D health state valuations using a nonparametric Bayesian method. Statistics in Medicine, 29(15), 1622–1634.PubMed
31.
Nan, L., Johnson, J. A., Shaw, J., & Coons, S. J. (2007). A comparison of EQ-5D index scores derived from the US and UK population-based scoring functions. Medical Decision Making, 27(3), 321–326.CrossRef
32.
Norman, R., Cronin, P., Viney, R., King, M., & Street, D. (2009). International comparison in valuing EQ-5D health states: A review and analysis. Value in Health, 12(8), 1194–1200.PubMedCrossRef
33.
Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press.
34.
Kind, P. (2009). Valuing EQ-5D health states—a VAStly simpler solution? In J. Busschbach, R. Rabin, & F. De Charro (Eds.), 24th scientific plenary meeting of the EuroQoL group—Proceedings, 2009 Sept 13–15; Kijkduin-The Hague, The Netherlands (pp. 319–337). Rotterdam: EuroQoL Group Executive Office.
35.
Leidl, R., & Reitmeir, P. (2011). A value set for the EQ-5D based on experienced health states. Development and testing for the German population. Pharmacoeconomics, 29(6), 521–534.PubMedCrossRef
36.
Rand-Hendriksen, K., Augestad, L. A., Kristiansen, I. S., & Stavem, K. (2012). Comparison of hypothetical and experienced EQ-5D valuations: Relative weights of five dimensions. Quality of Life Research, 21(6), 1005–1012.PubMedCrossRef
37.
Groot, W. (2000). Adaptation and scale of reference bias in self-assessments of quality of life. Journal of Health Economics, 19(3), 403–420.PubMedCrossRef
38.
Menzel, P., Dolan, P., Richardson, P., & Olsen, J. A. (2002). The role of adaptation to disability and disease in health state valuation: A preliminary normative analysis. Social Science and Medicine, 55(12), 2149–2158.PubMedCrossRef
39.
Ubel, P. A., Loewenstein, G., & Jepson, C. (2003). Whose quality of life? A commentary exploring discrepancy between health state evaluations of patients and the general public. Quality of Life Research, 12(6), 599–607.PubMedCrossRef
40.
41.
42.
Torrance, G. W. (1986). Measurement of health state utilities for economic appraisal: A review. Journal of Health Economics, 5(1), 1–30.PubMedCrossRef
43.
Bardage, C., Isacson, D., Ring, L., & Bingefors, K. (2003). A Swedish population-based study on the relationship between the SF-36 and health utilities to measure health in hypertension. Blood Pressure, 12(4), 203–210.PubMedCrossRef
44.
Lundberg, L., Johannesson, M., Isacson, D. G. L., & Borgquist, L. (1999). Health-state utilities in a general population in relation to age, gender and socioeconomic factors. European Journal of Public Health, 9(3), 211–217.CrossRef
45.
Williams, A. (1995). The measurement and valuation of health: A chronicle. Centre for Health Economics Discussion paper 136. York: University of York.
46.
White, A. (1980). A heteroscedasticity consistent covariance matrix estimator and a direct test of heteroscedasticity. Econometrica, 48, 817–838.CrossRef
47.
SAS Institute Inc. (2006). Base SAS ® 9.2. Procedures Guide (Second Ed, Vols. 1, 2, 3 and 4. Cary, NC: SAS Institute Inc.
48.
Björk, S., & Norinder, A. (1999). The weighting exercise for the Swedish version of the EuroQol. Health Economics, 8(2), 117–126.PubMedCrossRef
49.
Greiner, W., Claes, C., Busschbach, J. J. V., & Graf van der Schulenburg, J. M. (2005). Validating the EQ-5D with time trade-off for the German population. European Journal of Health Economics, 6(2), 124–130.PubMedCrossRef
50.
Lamers, L. M., McDonnell, J., Stalmeier, P. F. M., Krabbe, P. F. M., & Busschbach, J. J. V. (2006). The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Economics, 15(10), 1121–1132.PubMedCrossRef
51.
Tongsiri, S., & Cairns, J. (2011). Estimating population-based values for EQ-5D health states in Thailand. Value in Health, 14(8), 1142–1145.PubMedCrossRef
52.
Badia, X., Roset, M., & Herdman, M. (1999). Inkonsistent responses in the three preference-elicitation methods for health states. Social Science and Medicine, 49, 943–950.PubMedCrossRef
53.
Wittrup-Jensen, K. U., Lauridsen, J., Gudex, C., & Pedersen, K. M. (2009). Generation of a Danish TTO value set for EQ-5D health states. Scandinavian Journal of Public Health, 37(5), 459–466.PubMedCrossRef
54.
Polsky, D., Wilke, R. J., Scott, K., Schulman, K. A., & Glick, H. (2001). A comparison of scoring weights for EuroQol derived from patients and the general public. Health Economics, 10(1), 27–37.PubMedCrossRef
55.
Zethraeus, N., & Johannesson, M. (1999). A comparison of patient and social tariff values derived from the time trade-off method. Health Economics, 8(6), 541–545.PubMedCrossRef
56.
Björk, S., & Althin, R. (1991). Health states considered worse than being dead. In S. Björk (Ed.), EuroQol Conference Proceedings, IHE Working paper, 1991 Sept, Lund, Sweden (pp. 83–86). Lund: The Swedish Institute for Health Economics (IHE).
57.
Macran, S., & Kind, P. (2001). ‘Death’ and the valuation of health-related quality of life. Medical Care, 39(3), 217–227.PubMedCrossRef
58.
Burström, K., Johannesson, M., & Diderichsen, F. (2001). Swedish population health-related quality of life using the EQ-5D. Quality of Life Research, 10(7), 621–635.PubMedCrossRef
59.
van Doorslaer, E., & Jones, A. M. (2003). Inequalities in self-reported health: Validation of a new approach to measurement. Journal of Health Economics, 22(1), 61–87.PubMedCrossRef
60.
Lundberg, L., Johannesson, M., Isacson, D. G. L., & Borgquist, L. (1999). The relationship between health state utilities and the SF-36 in a general population. Medical Decision Making, 19(2), 128–140.PubMedCrossRef
61.
Dolan, P. (2009). NICE should value real experiences over hypothetical opinions. Nature, 462(7269), 35.PubMedCrossRef
62.
Leidl, R., Reitmeir, P., König, H. H., & Stark, R. (2012). The performance of a value set for the EQ-5D based on experienced health states in patients with inflammatory bowel disease. Value in Health, 15(1), 151–157.PubMedCrossRef
Metadata
Title
Swedish experience-based value sets for EQ-5D health states
Authors
Kristina Burström
Sun Sun
Ulf-G Gerdtham
Martin Henriksson
Magnus Johannesson
Lars-Åke Levin
Niklas Zethraeus
Publication date
01-03-2014
Publisher
Springer International Publishing
Published in
Quality of Life Research / Issue 2/2014
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-013-0496-4

Other articles of this Issue 2/2014

Quality of Life Research 2/2014 Go to the issue

Brief Communication

Use of factor analysis models to evaluate measurement invariance property of the Asthma Control Questionnaire (ACQ)

OriginalPaper

How do clinical and psychological variables relate to quality of life in end-stage renal disease? Validating a proximal–distal model

OriginalPaper

Is a diabetes pay-for-performance program cost-effective under the National Health Insurance in Taiwan?

OriginalPaper

How good is “very good”? Translation effect in the racial/ethnic variation in self-rated health status

OriginalPaper

Thirty down, only ten to go?! Awareness and influence of a 10-year time frame in TTO

OriginalPaper

The relationship between negative life events, psychological distress and life satisfaction: a population-based study